Some antimalarial drugs, such as hydroxychloroquine and quinacrine, have been used as potential treatments for SLE, and these inhibit IFN‐β production by binding to DNA and selectively blocking cGAS–dsDNA interactions. The gene discussed is CGAS; the disease is systemic lupus erythematosus.